Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made of the factors which they consider will most limit the roll out of the Oxford/Astrazeneca vaccine at scale; and what such factors they have identified.

We have invested over £300 million towards manufacturing and deploying successful vaccines in the United Kingdom, including ensuring we have adequate provision, transportation, personal protective equipment, and logistical expertise to do so.

All vaccines will present different logistical requirements, but the National Health Service has planned for all eventualities, including securing additional fridges to support the deployment of the Oxford/AstraZeneca vaccine.